Fosun-backed Gland Pharma readies Rp65bn IPO
qojoo - stock.adobe.com
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: